These results suggest that an increase in CMTM3 leads to an increase in cells such as cancer-associated fibroblasts, macrophages, myeloid dendritic cells, and endothelial cells, which can potentially modulate the protumor immune microenvironment to help tumors achieve immune escape. Here, CMTM3 is linked to cancer.